First AD

Second AD

Peter Riedell, MD, is an associate professor of medicine in the Section of Hematology/Oncology at the University of Chicago.

Guiding Patients Through CAR T: Key Discussion Points

Video content above is prompted by the following:

What do you share with your patients when counseling or first introducing CAR T-cell therapy?

Video Series

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Translating Clinical Data Into Patient Care: CAR T-Cell Therapy in DLBCL and CLL 

OncLive Insights

Experts discuss key points to share with patients when counseling or first introducing chimeric antigen receptor T-cell therapy (CAR T), focusing on expectations, potential adverse effects, and the treatment process